Repligen
RGEN
#2379
Rank
NZ$14.06 B
Marketcap
NZ$249.30
Share price
2.45%
Change (1 day)
18.91%
Change (1 year)
Categories

Repligen (RGEN) - Net assets

Net assets on the balance sheet as of March 2026 : NZ$3.68 Billion

According to Repligen 's latest financial reports the company has NZ$3.68 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Repligen - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$NZ$3.63 B3.96%
2024-12-31$NZ$3.49 B12.58%
2023-12-31$NZ$3.10 B3.24%
2022-12-31$NZ$3.00 B17.46%
2021-12-31$NZ$2.56 B20.9%
2020-12-31$NZ$2.11 B34.68%
2019-12-31$NZ$1.57 B71.47%
2018-12-31$NZ$0.91 B10.18%
2017-12-31$NZ$0.83 B241.87%
2016-12-31$NZ$0.24 B35.85%
2015-12-31$NZ$0.17 B25.77%
2014-12-31$NZ$0.14 B12.8%
2013-12-31$NZ$0.12 B23.62%
2012-12-31$NZ$0.10 B
2011-03-31$NZ$88.19 M-5.6%
2010-03-31$NZ$93.42 M-23.37%
2009-03-31$NZ$0.12 B52.89%
2008-03-31$NZ$79.73 M123.42%
2007-03-31$NZ$35.69 M-15.07%
2006-03-31$NZ$42.02 M23.07%
2005-03-31$NZ$34.14 M-16.1%
2004-03-31$NZ$40.69 M-8.22%
2003-03-31$NZ$44.33 M-26.11%
2002-03-31$NZ$60 M-22.86%
2001-03-31$NZ$77.78 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
NZ$158.27 B 4,193.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$91.14 B 2,372.67%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$32.03 B 769.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$35.19 B 854.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$10.92 M-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-NZ$0.26 Billion-106.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$5.96 B 61.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$3.65 B-0.96%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$10.87 B 195.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
NZ$5.23 B 41.93%๐Ÿ‡บ๐Ÿ‡ธ USA